Isomorphic Labs raises $5 billion for AI-powered drug design
Alphabet-backed biotech startup Isomorphic Labs has raised a $5 billion Series C round co-led by Greenoaks and Sequoia Capital. The company will use the funding, which brings its total raised to $7.7 billion, to develop its IsoDDE drug design engine and move its first drug candidates into clinical trials.